MCAM and hepatocellular carcinoma: A novel anti-CD146 mAb AA98 has been revealed that it can block angiogenesis both in vitro and in vivo, and it alone can effectively inhibit tumor growth of HCC xenografts via intraperitoneal injections (Yan et al., 2003).